These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 30776695)
1. Ligand-based design, synthesis and biochemical evaluation of potent and selective inhibitors of Schistosoma mansoni dihydroorotate dehydrogenase. Calil FA; David JS; Chiappetta ERC; Fumagalli F; Mello RB; Leite FHA; Castilho MS; Emery FS; Nonato MC Eur J Med Chem; 2019 Apr; 167():357-366. PubMed ID: 30776695 [TBL] [Abstract][Full Text] [Related]
2. Structural basis for the function and inhibition of dihydroorotate dehydrogenase from Schistosoma mansoni. de Mori RM; Aleixo MAA; Zapata LCC; Calil FA; Emery FS; Nonato MC FEBS J; 2021 Feb; 288(3):930-944. PubMed ID: 32428996 [TBL] [Abstract][Full Text] [Related]
3. Computer-aided discovery of novel SmDHODH inhibitors for schistosomiasis therapy: Ligand-based drug design, molecular docking, molecular dynamic simulations, drug-likeness, and ADMET studies. Ja'afaru SC; Uzairu A; Hossain S; Ullah MH; Sallau MS; Ndukwe GI; Ibrahim MT; Bayil I; Moin AT PLoS Negl Trop Dis; 2024 Sep; 18(9):e0012453. PubMed ID: 39264908 [TBL] [Abstract][Full Text] [Related]
4. Structural basis for the design of selective inhibitors for Schistosoma mansoni dihydroorotate dehydrogenase. Nonato MC; de Pádua RAP; David JS; Reis RAG; Tomaleri GP; D'Muniz Pereira H; Calil FA Biochimie; 2019 Mar; 158():180-190. PubMed ID: 30664899 [TBL] [Abstract][Full Text] [Related]
5. Compounds Derived from the Bhutanese Daisy, Ajania nubigena, Demonstrate Dual Anthelmintic Activity against Schistosoma mansoni and Trichuris muris. Wangchuk P; Pearson MS; Giacomin PR; Becker L; Sotillo J; Pickering D; Smout MJ; Loukas A PLoS Negl Trop Dis; 2016 Aug; 10(8):e0004908. PubMed ID: 27490394 [TBL] [Abstract][Full Text] [Related]
6. Dual Strategy to Design New Agents Targeting Fuchs N; Zimmermann RA; Schwickert M; Gunkel A; Zimmer C; Meta M; Schwickert K; Keiser J; Haeberli C; Kiefer W; Schirmeister T ACS Infect Dis; 2024 May; 10(5):1664-1678. PubMed ID: 38686397 [TBL] [Abstract][Full Text] [Related]
7. Ferrocenyl, Ruthenocenyl, and Benzyl Oxamniquine Derivatives with Cross-Species Activity against Schistosoma mansoni and Schistosoma haematobium. Hess J; Panic G; Patra M; Mastrobuoni L; Spingler B; Roy S; Keiser J; Gasser G ACS Infect Dis; 2017 Sep; 3(9):645-652. PubMed ID: 28686009 [TBL] [Abstract][Full Text] [Related]
8. Kinetics of inhibition of human and rat dihydroorotate dehydrogenase by atovaquone, lawsone derivatives, brequinar sodium and polyporic acid. Knecht W; Henseling J; Löffler M Chem Biol Interact; 2000 Jan; 124(1):61-76. PubMed ID: 10658902 [TBL] [Abstract][Full Text] [Related]
10. Discovery of Potent Inhibitors of Schistosoma mansoni NAD⁺ Catabolizing Enzyme. Jacques SA; Kuhn I; Koniev O; Schuber F; Lund FE; Wagner A; Muller-Steffner H; Kellenberger E J Med Chem; 2015 Apr; 58(8):3582-92. PubMed ID: 25803425 [TBL] [Abstract][Full Text] [Related]
11. An Abies procera-derived tetracyclic triterpene containing a steroid-like nucleus core and a lactone side chain attenuates in vitro survival of both Fasciola hepatica and Schistosoma mansoni. Whiteland HL; Chakroborty A; Forde-Thomas JE; Crusco A; Cookson A; Hollinshead J; Fenn CA; Bartholomew B; Holdsworth PA; Fisher M; Nash RJ; Hoffmann KF Int J Parasitol Drugs Drug Resist; 2018 Dec; 8(3):465-474. PubMed ID: 30399512 [TBL] [Abstract][Full Text] [Related]
12. Novel Non-Peptide Inhibitors against SmCL1 of Schistosoma mansoni: In Silico Elucidation, Implications and Evaluation via Knowledge Based Drug Discovery. Zafar A; Ahmad S; Rizvi A; Ahmad M PLoS One; 2015; 10(5):e0123996. PubMed ID: 25933436 [TBL] [Abstract][Full Text] [Related]
13. Large-scale RNAi screening uncovers therapeutic targets in the parasite Wang J; Paz C; Padalino G; Coghlan A; Lu Z; Gradinaru I; Collins JNR; Berriman M; Hoffmann KF; Collins JJ Science; 2020 Sep; 369(6511):1649-1653. PubMed ID: 32973031 [TBL] [Abstract][Full Text] [Related]
14. In Vitro and in Vivo Antischistosomal Activities of Chalcones. Pereira VRD; Junior IJA; da Silveira LS; Geraldo RB; de F Pinto P; Teixeira FS; Salvadori MC; Silva MP; Alves LA; Capriles PVSZ; das C Almeida A; Coimbra ES; Pinto PLS; Couri MRC; de Moraes J; Da Silva Filho AA Chem Biodivers; 2018 Dec; 15(12):e1800398. PubMed ID: 30276965 [TBL] [Abstract][Full Text] [Related]
15. Synthesis, Design, and Structure⁻Activity Relationship of the Pyrimidone Derivatives as Novel Selective Inhibitors of Xu L; Li W; Diao Y; Sun H; Li H; Zhu L; Zhou H; Zhao Z Molecules; 2018 May; 23(6):. PubMed ID: 29794978 [TBL] [Abstract][Full Text] [Related]
16. Praziquantel treatment of school children from single and mixed infection foci of intestinal and urogenital schistosomiasis along the Senegal River Basin: monitoring treatment success and re-infection patterns. Webster BL; Diaw OT; Seye MM; Faye DS; Stothard JR; Sousa-Figueiredo JC; Rollinson D Acta Trop; 2013 Nov; 128(2):292-302. PubMed ID: 23022016 [TBL] [Abstract][Full Text] [Related]
17. Impact of treatment with a Protein Tyrosine Kinase Inhibitor (Genistein) on acute and chronic experimental Schistosoma mansoni infection. Sobhy MMK; Mahmoud SS; El-Sayed SH; Rizk EMA; Raafat A; Negm MSI Exp Parasitol; 2018 Feb; 185():115-123. PubMed ID: 29331278 [TBL] [Abstract][Full Text] [Related]
18. Structure-Based Design and Synthesis of Novel Inhibitors Targeting HDAC8 from Schistosoma mansoni for the Treatment of Schistosomiasis. Heimburg T; Chakrabarti A; Lancelot J; Marek M; Melesina J; Hauser AT; Shaik TB; Duclaud S; Robaa D; Erdmann F; Schmidt M; Romier C; Pierce RJ; Jung M; Sippl W J Med Chem; 2016 Mar; 59(6):2423-35. PubMed ID: 26937828 [TBL] [Abstract][Full Text] [Related]
19. Quorum sensing N-Acyl homoserine lactones are a new class of anti-schistosomal. Whiteland H; Crusco A; Bloemberg LW; Tibble-Howlings J; Forde-Thomas J; Coghlan A; Murphy PJ; Hoffmann KF PLoS Negl Trop Dis; 2020 Oct; 14(10):e0008630. PubMed ID: 33075069 [TBL] [Abstract][Full Text] [Related]
20. Molluskicidal activity of 3-aryl-2-hydroxy-1,4-naphthoquinones against Biomphalaria glabrata. Martins DL; do Amaral E Silva NA; Ferreira VF; Rangel LDS; Dos Santos JAA; Faria RX Acta Trop; 2022 Jul; 231():106414. PubMed ID: 35346667 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]